Clinical Trial Update: Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2a clinical trial of SQY51 in pediatric and adult patients with Duchenne Muscular Dystrophy is underway to assess safety, pharmacokinetics, and pharma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• SQY51

Snippet

Sponsor: Sqy Therapeutics | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: UNKNOWN